Literature DB >> 20393482

Acrosyringium is the main site of the vesicle/pustule formation in palmoplantar pustulosis.

Masamoto Murakami1, Takaaki Ohtake, Yoshimune Horibe, Akemi Ishida-Yamamoto, Vera B Morhenn, Richard L Gallo, Hajime Iizuka.   

Abstract

Pustulosis palmaris et plantaris or palmoplantar pustulosis (PPP) is a refractory pustular eruption on the palms and soles with unknown etiology. Numerous eccrine sweat pores exist on the palms and soles, suggesting the involvement of eccrine sweating in the pathogenesis of PPP. To the best of our knowledge, however, no definite abnormality in sweating has been documented in PPP. Accordingly, we analyzed the eccrine sweat duct involvement in the mechanism of vesicle formation in PPP. Dermatoscopy showed that PPP vesicles are located on the top of the ridges but not in the furrows. The sweat secretion in the lesional area was much lower than that in the nonlesional area, with or without pain stimulation to induce sweating. Immunostaining of horizontal sections of the lesions using antibodies against gross cystic disease fluid protein-15 (GCDFP-15) and epithelial membrane antigen (EMA) showed that these markers were localized in the cells lining the intraepidermal vesicles. Although the sweat antimicrobial peptides, dermcidin and human cathelicidin antimicrobial peptide 18 (hCAP-18)/LL-37, were detected in the fluid of the vesicles/pustules, neither dermcidin nor hCAP-18/LL-37 were overexpressed by neighboring keratinocytes. These findings suggest that the acrosyringium may be involved as the main site of the vesicle formation in the pathomechanism of PPP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393482     DOI: 10.1038/jid.2010.87

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  [Pustular psoriasis].

Authors:  P Weisenseel; D Wilsmann-Theis; C Kahl; K Reich; R Mössner
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

2.  Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial.

Authors:  Tadashi Terui; Satomi Kobayashi; Yukari Okubo; Masamoto Murakami; Keiichiro Hirose; Hiroshi Kubo
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

3.  Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis.

Authors:  Masamoto Murakami; Takaaki Kaneko; Teruaki Nakatsuji; Kenji Kameda; Hidenori Okazaki; Xiuju Dai; Yasushi Hanakawa; Mikiko Tohyama; Akemi Ishida-Yamamoto; Koji Sayama
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

Review 4.  Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.

Authors:  Magdalena Misiak-Galazka; Joanna Zozula; Lidia Rudnicka
Journal:  Am J Clin Dermatol       Date:  2020-06       Impact factor: 7.403

5.  High-quality Fluorescence Imaging of the Human Acrosyringium Using a Transparency: Enhancing Technique and an Improved, Fluorescent Solvatochromic Pyrene Probe.

Authors:  Masamoto Murakami; Ryosuke Kawakami; Yosuke Niko; Teruko Tsuda; Hideki Mori; Kazuki Yatsuzuka; Takeshi Imamura; Koji Sayama
Journal:  Acta Histochem Cytochem       Date:  2020-11-21       Impact factor: 1.938

6.  Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis.

Authors:  Tae Hyung Kim; Ji Su Kim; Ji Eun Kwon; Bumhee Park; Eun-So Lee
Journal:  Ann Dermatol       Date:  2022-01-27       Impact factor: 1.444

Review 7.  Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.

Authors:  Toshiyuki Yamamoto
Journal:  Clin Pharmacol       Date:  2021-06-23

8.  Interventions for chronic palmoplantar pustulosis.

Authors:  Grace Obeid; Giao Do; Lisa Kirby; Carolyn Hughes; Emilie Sbidian; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2020-01-20

9.  Eccrine sweat contains IL-1α, IL-1β and IL-31 and activates epidermal keratinocytes as a danger signal.

Authors:  Xiuju Dai; Hidenori Okazaki; Yasushi Hanakawa; Masamoto Murakami; Mikiko Tohyama; Yuji Shirakata; Koji Sayama
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

Review 10.  Pustular psoriasis: pathophysiology and current treatment perspectives.

Authors:  Katie E Benjegerdes; Kimberly Hyde; Dario Kivelevitch; Bobbak Mansouri
Journal:  Psoriasis (Auckl)       Date:  2016-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.